Jove
Visualize
Contact Us

Related Concept Videos

Stimulants01:29

Stimulants

1.1K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

696
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
696
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

972
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
972
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

674
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
674

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

State Law Variation Regarding Informed Consent for Sexual Assault Medical Forensic Exams With Adolescents.

Journal of forensic nursing·2026
Same author

Caution Is Warranted in Prescribing Ketamine for Mental Health.

Journal of general internal medicine·2025
Same author

Three Roles for Clinical Ethicists to Provide Clarity and Guidance on Physician-Assisted Suicide/Euthanasia.

Bioethics·2025
Same author

Addressing the Problem of Brain Death Misdiagnosis.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2025
Same author

Leveraging law and ethics to promote safe and reliable AI/ML in healthcare.

Frontiers in nuclear medicine·2024
Same author

The Problem with Using Medical Boards to Regulate Misinformation.

The Journal of legal medicine·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 22, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.2K

Risks of Improper Stimulant Prescribing With Telemedicine-Only Platforms.

B Scotty Mooney, Katherine Drabiak, Sylvia Fogel

    The Journal of Legal Medicine
    |February 20, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Telemedicine for attention-deficit/hyperactivity disorder (ADHD) expanded during COVID-19 due to relaxed prescribing rules and interstate licensing. This shift presents challenges in ensuring safe stimulant prescribing and preventing misuse.

    Keywords:
    Legal liabilityattention-deficit disorder with hyperactivitycontrolled substanceslicensuretelemedicine

    More Related Videos

    Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
    08:22

    Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

    Published on: October 7, 2017

    8.6K
    A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
    08:18

    A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

    Published on: December 26, 2015

    18.1K

    Related Experiment Videos

    Last Updated: Feb 22, 2026

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    8.2K
    Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
    08:22

    Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

    Published on: October 7, 2017

    8.6K
    A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
    08:18

    A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

    Published on: December 26, 2015

    18.1K

    Area of Science:

    • Healthcare Law
    • Telemedicine
    • Psychiatry

    Background:

    • The COVID-19 pandemic accelerated the adoption of telemedicine for mental health treatment.
    • Direct-to-consumer telemedicine-only corporations emerged, treating conditions like attention-deficit/hyperactivity disorder (ADHD).
    • Regulatory changes, including temporary rule suspensions by the Drug Enforcement Administration and modified state licensing, facilitated this growth.

    Purpose of the Study:

    • To provide an overview of the legal landscape governing telemedicine for ADHD treatment.
    • To examine prescribing requirements, licensing, and prescription drug monitoring programs.
    • To discuss the implications of telehealth-only models on quality, safety, and regulatory compliance.

    Main Methods:

    • Review of relevant laws and regulations concerning telemedicine prescribing and licensing.
    • Analysis of temporary rules and state-level modifications impacting healthcare delivery.
    • Examination of legal consequences for improper prescribing practices.

    Main Results:

    • Temporary rule changes allowed remote prescribing of controlled substances without prior in-person exams.
    • Modified state licensing enabled cross-state patient treatment via telemedicine.
    • Telehealth-only models introduce new challenges for quality assurance, safety, and preventing diversion of stimulant medications.

    Conclusions:

    • The expansion of telemedicine for ADHD treatment necessitates careful consideration of legal frameworks.
    • Ensuring quality, safety, and preventing misuse of stimulant medications are critical concerns.
    • Improper prescribing carries significant legal risks, including administrative sanctions and criminal liability.